Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Sein
- | Specialty :
- Thérapies Ciblées
Extract
A randomized, double-blind, multi-center phase II trial of exemestane (Aromasin®) plus dasatinib versus exemestane plus placebo in advanced ER+ breast cancer after disease progression on a non-steroidal aromatase inhibitor.
Scientific Abstract
en cours d'intégration;